Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

W.M. de Vos (Inventor)

Research output: PatentOther research output

Abstract

The invention is concerned with a novel human intestinal isolate capable of converting L- lysine into butyrate and/or of converting fructose-lysine into butyrate. The novel isolate can be used as a probiotic or supplement to promote production of butyrate in the Gl tract, thereby preventing and/or treating conditions or diseases that benefit from the production of butyrate. Additionally, the isolate may prevent and/or treat conditions or diseases caused by an excess of pathogenic bacteria in the Gl tract, mediated by L-lysine, or mediated by fructose-lysine or other advanced glycation end products.
Original languageEnglish
Patent numberWO2016110585
Priority date9/01/15
Publication statusPublished - 14 Jul 2016

Fingerprint Dive into the research topics of 'Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases'. Together they form a unique fingerprint.

Cite this